Rare Disease Day 2023: GenSight Biologics Raises Awareness of Leber Hereditary Optic Neuropathy (LHON)

Leber Hereditary Optic Neuropathy (LHON) is a rare disease predominantly affecting people aged 15 to 35 year that causes irreversible and severe vision loss, resulting in blindness Patients

Related Keywords

United Kingdom ,Germany ,Italy ,Canada ,Toronto ,Ontario ,France ,Framke ,Niedersachsen ,Canadian ,Dennis Riedl ,Clothilde Caillet ,James Palmer ,Gensight Biologics Euronext ,Guillaume Van Renterghem ,Jeanene Timberlake ,Gensight Biologics ,Ophthalmol Clin ,University Of Washington ,Corporate Communications ,Canadian Ophthalmology Society Annual Meeting ,International Consensus Statement ,Lancet Glob Health ,Leber Hereditary Optic Neuropathy ,Sight Biologics ,Rare Disease Day ,Disease Day ,Hereditary Optic Neuropathy ,Leber Hereditary Optic Neuropathy Patients With ,Leber Hereditary Optic ,Int Ophthalmol ,Arch Clin Exp ,Eur Ophthalmic ,Hereditary Optic ,Ophthalmol Vis ,Lancet Global Health Commission ,Global Eye Health ,Their Relatives ,Suicidal Ideation ,Ophthalmology Society Annual Meeting ,Consensus Statement ,Therapeutic Management ,Sight Biologic ,Mitochondrial Targeting Sequence ,Communications Director ,Rare ,Disease ,023 ,Gensight ,Iologics ,Raises ,Awareness ,Eber ,Hereditary ,Optic ,Neuropathy ,Hon ,